Andreas Herrmann

501 total citations
14 papers, 351 citations indexed

About

Andreas Herrmann is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Andreas Herrmann has authored 14 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Andreas Herrmann's work include Monoclonal and Polyclonal Antibodies Research (6 papers), interferon and immune responses (3 papers) and Immunotherapy and Immune Responses (3 papers). Andreas Herrmann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), interferon and immune responses (3 papers) and Immunotherapy and Immune Responses (3 papers). Andreas Herrmann collaborates with scholars based in Germany, Netherlands and United States. Andreas Herrmann's co-authors include Roland E. Kontermann, Klaus Pfizenmaier, Peter Scheurich, Eric Guenzi, Roman Fischer, Ulrich Eisel, Olaf Maier, Fabian Richter, Petrus J.W. Naudé and Eddy A. van der Zee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Andreas Herrmann

13 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Herrmann Germany 9 169 115 90 70 53 14 351
Shenyi Jiang China 12 89 0.5× 149 1.3× 101 1.1× 28 0.4× 44 0.8× 22 371
Prameladevi Chinnasamy United States 12 170 1.0× 130 1.1× 44 0.5× 24 0.3× 44 0.8× 14 388
Carolyn J. Hoban United States 7 152 0.9× 132 1.1× 74 0.8× 101 1.4× 25 0.5× 11 472
Marc Lamarine Switzerland 8 166 1.0× 166 1.4× 61 0.7× 32 0.5× 15 0.3× 10 467
Julie A. Kawczak United States 10 312 1.8× 121 1.1× 82 0.9× 40 0.6× 19 0.4× 13 520
Raül Tortosa Spain 13 59 0.3× 224 1.9× 30 0.3× 77 1.1× 33 0.6× 21 419
Sonia Gavasso Norway 12 90 0.5× 102 0.9× 58 0.6× 15 0.2× 35 0.7× 26 300
Noriko Fukumoto Japan 4 280 1.7× 101 0.9× 185 2.1× 59 0.8× 65 1.2× 6 466
Alma N. Mohebiany Germany 8 198 1.2× 129 1.1× 41 0.5× 40 0.6× 35 0.7× 8 357
Ribal Bassil United States 10 484 2.9× 256 2.2× 85 0.9× 110 1.6× 54 1.0× 10 689

Countries citing papers authored by Andreas Herrmann

Since Specialization
Citations

This map shows the geographic impact of Andreas Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Herrmann more than expected).

Fields of papers citing papers by Andreas Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Herrmann. The network helps show where Andreas Herrmann may publish in the future.

Co-authorship network of co-authors of Andreas Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Herrmann. A scholar is included among the top collaborators of Andreas Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Herrmann. Andreas Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hagelstein, Ilona, Joseph Kauer, Hans‐Georg Rammensee, et al.. (2022). IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases. Cancers. 14(16). 3941–3941. 2 indexed citations
2.
Richter, Fabian, Sarah K. Williams, Katharina John, et al.. (2021). The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation. Frontiers in Immunology. 12. 705485–705485. 25 indexed citations
3.
Herrmann, Andreas, Toshikage Nagao, Chunyan Zhang, et al.. (2019). An effective cell-penetrating antibody delivery platform. JCI Insight. 4(14). 20 indexed citations
4.
Richter, Fabian, Oliver Seifert, Andreas Herrmann, Klaus Pfizenmaier, & Roland E. Kontermann. (2019). Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. mAbs. 11(4). 653–665. 15 indexed citations
5.
Williams, Sarah K., Richard Fairless, Olaf Maier, et al.. (2018). Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis. Scientific Reports. 8(1). 13628–13628. 45 indexed citations
6.
Richter, Fabian, Kirstin A. Zettlitz, Oliver Seifert, et al.. (2018). Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity. mAbs. 11(1). 166–177. 17 indexed citations
7.
Dong, Yun, Roman Fischer, Petrus J.W. Naudé, et al.. (2016). Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Proceedings of the National Academy of Sciences. 113(43). 12304–12309. 123 indexed citations
8.
Williams, Sarah K., Olaf Maier, Roman Fischer, et al.. (2014). Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis. Journal of Neuroimmunology. 275(1-2). 178–179. 3 indexed citations
9.
Richter, Fabian, Eric Guenzi, Andreas Herrmann, et al.. (2013). Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity. PLoS ONE. 8(8). e72156–e72156. 34 indexed citations
10.
Egli, Simon, et al.. (2011). Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP. BMC Proceedings. 5(S8). P42–P42. 2 indexed citations
11.
Zettlitz, Kirstin A., Verena Lorenz, Sabine Münkel, et al.. (2010). ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody. mAbs. 2(6). 639–647. 50 indexed citations
12.
Herrmann, Andreas & Mark Heitmann. (2005). Den Kaufrausch nutzen. Alexandria (UniSG) (University of St.Gallen). 1 indexed citations
13.
Giese, Bernd, Andreas Herrmann, Jürgen Stahl, et al.. (2001). Signal transducer gp130: biochemical characterization of the three membrane-proximal extracellular domains and evaluation of their oligomerization potential. Biochemical Journal. 356(2). 605–605. 9 indexed citations
14.
Giese, Bernd, Andreas Herrmann, Jürgen Stahl, et al.. (2001). Signal transducer gp130: biochemical characterization of the three membrane-proximal extracellular domains and evaluation of their oligomerization potential. Biochemical Journal. 356(2). 605–612. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026